Cancer Nanomedicines Based on Synthetic Polypeptides
- 29 October 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 20 (12) , 4299-4311
Abstract
Nanomedicines are deemed as a most promising treatment modality for malignant cancers. Particularly, cancer nanomedicines based on synthetic polypeptides have gained interest because they possess excellent safety, unique hierarchical structure, and tailorable functionalities to suit for delivery of diverse drugs including synthetic drugs, peptides, proteins, and nucleic acids. A few polypeptide-based nanoformulations (e.g. NK105, NC6004, NK911, CT2103) are under phase I-III clinical investigation for treating patients with advanced solid tumors. In recent years, progress has been made in development of robust and high drug loading, tumor-targeting, membrane-disrupting, and/or stimuli-sensitive nanomedicines from de novo functional polypeptides, which afford not only better safety and reduced adverse effects but also further improved anti-cancer efficacy over clinical formulations. Moreover, virus-mimicking vehicles have been devised from polypeptides for efficient non-viral delivery of highly potent peptides, proteins, and nucleic acids, greatly advancing biotherapy for cancers. In this perspective, we highlight the state-of-the-art design and fabrication of cancer nanomedicines based on synthetic polypeptides, and at the end give our viewpoints on their future development for targeted cancer therapy and potential challenges for clinical translation.Keywords
Funding Information
- National Natural Science Foundation of China (51603139, 51633005, 51973149, 51773145)
This publication has 118 references indexed in Scilit:
- Reactive and Bioactive Cationic α‐Helical Polypeptide Template for Nonviral Gene DeliveryAngewandte Chemie International Edition, 2011
- Stimuli‐Sensitive Synthetic Polypeptide‐Based Materials for Drug and Gene DeliveryAdvanced Healthcare Materials, 2011
- Polymersomes Spanning from Nano- to Microscales: Advanced Vehicles for Controlled Drug Delivery and Robust Vesicles for Virus and Cell MimickingThe Journal of Physical Chemistry Letters, 2011
- Polyion complex stability and gene silencing efficiency with a siRNA-grafted polymer delivery systemBiomaterials, 2010
- Intratracheal Gene Transfer of Adrenomedullin Using Polyplex Nanomicelles Attenuates Monocrotaline-induced Pulmonary Hypertension in RatsMolecular Therapy, 2009
- Polymer-drug conjugates: Recent development in clinical oncologyAdvanced Drug Delivery Reviews, 2008
- Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivativesJournal of Controlled Release, 2008
- Bone Regeneration by Regulated In Vivo Gene Transfer Using Biocompatible Polyplex NanomicellesMolecular Therapy, 2007
- Semipermeable Polymer Vesicle (PICsome) Self-Assembled in Aqueous Medium from a Pair of Oppositely Charged Block Copolymers: Physiologically Stable Micro-/Nanocontainers of Water-Soluble MacromoleculesJournal of the American Chemical Society, 2006
- Transition Metal−Amine Initiators for Preparation of Well-Defined Poly(γ-benzyl l-glutamate)Journal of the American Chemical Society, 1997